Home > Cashflow Statement > BETA DRUGS

BETA DRUGS
Cash Flow from Operating Activities

    Back to Cashflow Statement
BETA DRUGS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹36 Cr₹31 Cr₹23 Cr₹30 Cr₹19 Cr

What is the latest Cash Flow from Operating Activities ratio of BETA DRUGS ?

The latest Cash Flow from Operating Activities ratio of BETA DRUGS is ₹36 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹36 Cr
Mar2024₹31 Cr
Mar2023₹23 Cr
Mar2022₹30 Cr
Mar2021₹19 Cr

How is Cash Flow from Operating Activities of BETA DRUGS Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹36 Cr
16.86
Mar2024 ₹31 Cr
32.28
Mar2023 ₹23 Cr
-21.08
Mar2022 ₹30 Cr
59.29
Mar2021 ₹19 Cr -

Compare Cash Flow from Operating Activities of peers of BETA DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BETA DRUGS ₹2,443.1 Cr -4.6% -0.1% 12.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹460,696.0 Cr 0.5% -4% 15.7% Stock Analytics
DIVIS LABORATORIES ₹246,063.0 Cr 9.1% 18.2% 47.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,515.0 Cr 3.6% 3.4% 36.4% Stock Analytics
CIPLA ₹114,554.0 Cr -1.2% -3.3% -10.8% Stock Analytics
DR REDDYS LABORATORIES ₹98,308.6 Cr -1.4% 2.9% -8% Stock Analytics


BETA DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BETA DRUGS

-4.6%

-0.1%

12.8%

SENSEX

-0.4%

-0.5%

-5.8%


You may also like the below Video Courses